GlassScriptPhysician profile
Laura Ashley Eulitz
NPI 1740854330
$3,336.41
in general payments reported to CMS, 2019-2025
19 companies · $86.35 in 2025
The $86.35 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $2,119 · 2023: $453 · 2024: $395 · 2025: $86.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventric Diagnostics, INC. | $905.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $449.10 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $306.04 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $264.08 | 2021-2024 | Wainua, Brilinta, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $193.61 | 2021-2025 | Eliquis, Camzyos |
| Pfizer INC. | $193.57 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.99 | 2022-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.49 | 2021-2022 | |
| Edwards Lifesciences Corporation | $159.75 | 2024 | Sapien 3 Ultra Resilia |
| Amgen INC. | $148.42 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $99.17 | 2022-2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $90.13 | 2021-2022 | |
| Novo Nordisk INC | $68.61 | 2021-2023 | Rybelsus, Ozempic |
| Boston Scientific Corporation | $24.75 | 2023 | Watchman Access System |
| Sanofi-Aventis U.S. LLC | $19.99 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $18.58 | 2024 | Inspire |
| Scpharmaceuticals INC. | $17.30 | 2024 | |
| Amarin Pharma, INC. | $15.38 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Eulitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.